EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Amgen Inc (AMGN) in Franklin Biotechnology Discovery Fund Q2 2024
HHS Rejects Amgen, Lilly Fight of Clinics in Drug Discount Plan
Alston & Bird Allege Big Pharma Company Amgen Monopolized US Arthritis Drug Market
Savvy Advisors Inc. Buys 2,087 Shares of Amgen Inc. (NASDAQ:AMGN)
Stamos Capital Partners L.P. Boosts Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
Townsquare Capital LLC Has $8.38 Million Position in Amgen Inc. (NASDAQ:AMGN)
Remission induction in refractory, drug resistant pediatric PICALM::MLLT10 + B-cell acute lymphoblastic leukemia by venetoclax
[Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to ...
Sandoz Files Antitrust Lawsuit Against Amgen Over Enbrel
Petros Family Wealth LLC Takes Position in Amgen Inc. (NASDAQ:AMGN)
LSV Asset Management Sells 470,060 Shares of Amgen Inc. (NASDAQ:AMGN)
Sandoz (SDZNY) Files Antitrust Lawsuit Against Amgen Over Market
Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US | The Manila Times
Sandoz files antitrust litigation against Amgen regarding patient access to etanercept ...
Sandoz Files Antitrust Lawsuit Against Amgen on Etanercept
Genetics can spike Indians' cholesterol, but relief may be at hand | Mint
Philadelphia Trust Co. Lowers Holdings in Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Neuberger Berman Group LLC
Scotia Capital Inc. Sells 7,208 Shares of Amgen Inc. (NASDAQ:AMGN)
Addition of metformin to anti-PD-1/PD-L1 drugs activates anti-tumor immune response in peripheral immune cells of NSCLC patients
Amgen (NASDAQ:AMGN) Shares Gap Down - Here's What Happened
Morgan Stanley Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock
Amgen's (AMGN) Imdelltra Shows Promising Results in Lung Cancer Trial
Amgen (AMGN) Announces Positive Results from Imdelltra Trial for Lung Cancer | AMGN Stock News
IMDELLTRA® DEMONSTRATED SUPERIOR OVERALL SURVIVAL IN SMALL CELL
APG Asset Management US Inc. Sells 1,344 Shares of Amgen Inc. (NASDAQ:AMGN)
Amgen Inc (AMGN) Shares Gap Down to $275.875 on Apr 10
APG Asset Management N.V. Buys 456,514 Shares of Amgen Inc. (NASDAQ:AMGN)
1,747 Shares in Amgen Inc. (NASDAQ:AMGN) Bought by Tandem Investment Partners LLC
Abacus FCF Advisors LLC Grows Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
Bank of Nova Scotia Acquires 311,604 Shares of Amgen Inc. (NASDAQ:AMGN)
Shelton Capital Management Sells 90,975 Shares of Amgen Inc. (NASDAQ:AMGN)
Amgen (NASDAQ:AMGN) Upgraded at StockNews.com | MarketBeat
Why drug stocks are no longer a safe haven from the stock market's turmoil | Morningstar
Pfizer, Amgen, Johnson & Johnson, others drop at US market open amid Trump's US pharma tariff fears | Stock Market News
Canopy Partners LLC Purchases 1,662 Shares of Amgen Inc. (NASDAQ:AMGN)
U S Wealth Group LLC. Purchases New Shares in Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Legal & General Group Plc
Invesco Ltd. Increases Position in Amgen Inc. (NASDAQ:AMGN)
Bank of Montreal Can Acquires 46,030 Shares of Amgen Inc. (NASDAQ:AMGN)
Bell Asset Management Ltd Has $4.89 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Sumitomo Mitsui Financial Group Inc.
Cerity Partners LLC Sells 6,135 Shares of Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Trek Financial LLC
Bone Metastasis in Solid Tumors Market Set to Grow Substantially Through 2034, DelveInsight Projects | NanaBis, Actuate Therapeutics, Mabwell Bioscience, Hoffmann-La Roche, Novartis, Upjohn, INSYS | ABNewswire
Colorectal Cancer Market Poised for Steady Growth with a CAGR of 5% through 2034 | DelveInsight | ABNewswire
Autologous T cell therapy for PRAME + advanced solid tumors in HLA-A*02 + patients: a phase 1 trial
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Unigestion Holding SA
Federated Hermes Inc. Has $357.50 Million Holdings in Amgen Inc. (NASDAQ:AMGN)
Peapack Gladstone Financial Corp Trims Stake in Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Quadrant Capital Group LLC
This type of cholesterol is a risk factor for heart disease. Emerging drugs from Lilly and Amgen could treat it. | Company Business News
Ilmarinen Mutual Pension Insurance Co Raises Stake in Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Payden & Rygel
Aviva PLC Has $84.38 Million Holdings in Amgen Inc. (NASDAQ:AMGN)
Proxy Statement (Form DEF 14A) - Insurance News | InsuranceNewsNet
Prudential PLC Sells 27,860 Shares of Amgen Inc. (NASDAQ:AMGN)
The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into Tregs
Opportunities and challenges for MRD assessment in the clinical management of multiple myeloma
Envestnet Asset Management Inc. Has $330.26 Million Stock Position in Amgen Inc. (NASDAQ:AMGN)
Peapack Gladstone Financial Corp Sells 2,078 Shares of Amgen Inc. (NASDAQ:AMGN)
852 Shares in Amgen Inc. (NASDAQ:AMGN) Acquired by Leeward Financial Partners LLC
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Smith Moore & CO.
Amgen Inc. (NASDAQ:AMGN) Stock Position Raised by Atlas Capital Advisors Inc.
World Investment Advisors Boosts Holdings in Amgen Inc. (NASDAQ:AMGN)
Amgen (AMGN) Stands Out with Strong Dividend Policy
Pitcairn Co. Has $3.86 Million Stake in Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Stock Position Lifted by OneAscent Financial Services LLC
Huntington National Bank Raises Holdings in Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Meeder Asset Management Inc.
US FDA approves Amgen's Uplizna as first treatment for rare immune disorder
Amgen (AMGN) Rises Amid Tariff Announcements
Amgen (AMGN) Gains FDA Approval for Expanded Uplizna Use in IgG4-RD
Amgen Inc (AMGN) Announces FDA Approval of UPLIZNA for IgG4-Related Disease
FDA Approves Second Indication for Amgen's Immune System Treatment Uplizna | Morningstar
Final Trades: Amgen, Sabra Health Care and Kinsale Capital Group
Potomac Fund Management Inc. ADV Invests $483,000 in Amgen Inc. (NASDAQ:AMGN)
Groupama Asset Managment Trims Stock Position in Amgen Inc. (NASDAQ:AMGN)
Uplizna (inebilizumab-cdon) is Now the First and Only FDA-Approved Treatment for IgG4-Related Disease
Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
Intrepid Capital Management Inc. Has $575,000 Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
1,255 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by May Hill Capital LLC
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Geode Capital Management LLC
Tradewinds LLC. Purchases 2,716 Shares of Amgen Inc. (NASDAQ:AMGN)
These biotech names aren't facing 'huge concern' from tariffs
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Franklin Resources Inc.
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Cannell & Spears LLC
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Skba Capital Management LLC
An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma
Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapy
O Shaughnessy Asset Management LLC Sells 5,429 Shares of Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Joseph Group Capital Management
Amgen Inc. (NASDAQ:AMGN) Shares Sold by RWA Wealth Partners LLC
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Loomis Sayles & Co. L P
Brown Brothers Harriman & Co. Decreases Position in Amgen Inc. (NASDAQ:AMGN)
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism
Latest news
Stock market today: Most Asian stocks fell after US equities declined
MicroStrategy joins Nasdaq-100 index: MSTR stock performance analysis 2024
Morning Note: Tesla Soars, AUDUSD Hits Key Support, Oil & SP500 Insights
Nikkei 225 up 1.39%: Japanese Stocks Rise Following Yen's Continued Weakness
